Dr. Gutberlet is a renowned researcher in Neuropsychology, works as a reviewer for various scientific journals and has served as juror for several national and international scientific prizes.
Since 12 years, Dr. Gutberlet is President of BlindSight GmbH, a German company specializing in Biosignal Methods consulting and development as well as Clinical Trials services for the Pharmaceutical Industry. During this time, he also served as the President of BrainVision LLC and as Scientific & Support Manager at Brain Products GmbH, a leading manufacturer of EEG equipment and software.
Prior to this, he spent 6 years working as an Assistant Professor and Senior Researcher at the Department of Biological and Clinical Psychology at the University of Jena. Dr. Gutberlet is a psychologist holding a PhD in Psychobiology and –physiology from the University of Trier in Germany. He published numerous scientific papers and book chapters on the CNS and peripheral effects of emotional, subliminal and other stimuli using EEG/ExG, MEG and MRI technology; and lately with a special focus on the development and evaluation of state of the art signal analysis methods for the integration of EEG and MRI in combined EEG/MRI recordings.
“We are proud that such a renowned and respected researcher with a strong academic and industry background has joined the SMI team”, says Eberhard Schmidt, Managing Director at SMI. “Ingmar’s knowledge will help to translate the needs of our research customers into even better solutions for their scientific work. His wealth of experience in different regional markets will further drive the scope of our international sales activities.”
About SensoMotoric Instruments (SMI)
Contact: Stefanie Gehrke, Market Communication Manager, stefanie.gehrke@